BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 22290531)

  • 21. Anemia of inflammation: the hepcidin link.
    Roy CN; Andrews NC
    Curr Opin Hematol; 2005 Mar; 12(2):107-11. PubMed ID: 15725899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low anticoagulant heparin-iron complex targeting inhibition of hepcidin ameliorates anemia of chronic disease in rodents.
    Li L; Wang X; Zhang H; Chen Q; Cui H
    Eur J Pharmacol; 2021 Apr; 897():173958. PubMed ID: 33610598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling.
    Fillebeen C; Wilkinson N; Charlebois E; Katsarou A; Wagner J; Pantopoulos K
    Blood; 2018 Oct; 132(17):1829-1841. PubMed ID: 30213871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.
    Schwoebel F; van Eijk LT; Zboralski D; Sell S; Buchner K; Maasch C; Purschke WG; Humphrey M; Zöllner S; Eulberg D; Morich F; Pickkers P; Klussmann S
    Blood; 2013 Mar; 121(12):2311-5. PubMed ID: 23349391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases.
    Poggiali E; Migone De Amicis M; Motta I
    Eur J Intern Med; 2014 Jan; 25(1):12-7. PubMed ID: 23988263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo.
    Sakamori R; Takehara T; Tatsumi T; Shigekawa M; Hikita H; Hiramatsu N; Kanto T; Hayashi N
    J Gastroenterol; 2010 Feb; 45(2):244-8. PubMed ID: 20091060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.
    Finberg KE; Whittlesey RL; Fleming MD; Andrews NC
    Blood; 2010 May; 115(18):3817-26. PubMed ID: 20200349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular basis of iron overload disorders and iron-linked anemias.
    Kaplan J; Ward DM; De Domenico I
    Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo.
    Theurl I; Schroll A; Nairz M; Seifert M; Theurl M; Sonnweber T; Kulaksiz H; Weiss G
    Haematologica; 2011 Dec; 96(12):1761-9. PubMed ID: 21859731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.
    Babitt JL; Lin HY
    Am J Kidney Dis; 2010 Apr; 55(4):726-41. PubMed ID: 20189278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.
    Ganz T
    Blood; 2003 Aug; 102(3):783-8. PubMed ID: 12663437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepcidin and iron homeostasis.
    Ganz T; Nemeth E
    Biochim Biophys Acta; 2012 Sep; 1823(9):1434-43. PubMed ID: 22306005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD.
    Casanovas G; Mleczko-Sanecka K; Altamura S; Hentze MW; Muckenthaler MU
    J Mol Med (Berl); 2009 May; 87(5):471-80. PubMed ID: 19229506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways.
    Shin DY; Chung J; Joe Y; Pae HO; Chang KC; Cho GJ; Ryter SW; Chung HT
    Blood; 2012 Mar; 119(11):2523-32. PubMed ID: 22262759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia.
    Cheng PP; Jiao XY; Wang XH; Lin JH; Cai YM
    Clin Exp Med; 2011 Mar; 11(1):33-42. PubMed ID: 20499129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiologic mechanisms of anemia of chronic disease.
    Andrews NC
    Postgrad Med; 2004 Nov; 116(5 Suppl Anemia):17-22. PubMed ID: 19667680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low hepcidin accounts for the proinflammatory status associated with iron deficiency.
    Pagani A; Nai A; Corna G; Bosurgi L; Rovere-Querini P; Camaschella C; Silvestri L
    Blood; 2011 Jul; 118(3):736-46. PubMed ID: 21628413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation.
    Steinbicker AU; Sachidanandan C; Vonner AJ; Yusuf RZ; Deng DY; Lai CS; Rauwerdink KM; Winn JC; Saez B; Cook CM; Szekely BA; Roy CN; Seehra JS; Cuny GD; Scadden DT; Peterson RT; Bloch KD; Yu PB
    Blood; 2011 May; 117(18):4915-23. PubMed ID: 21393479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anemia of Inflammation: A Review.
    Fraenkel PG
    Med Clin North Am; 2017 Mar; 101(2):285-296. PubMed ID: 28189171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepcidin and ferroportin: the new players in iron metabolism.
    De Domenico I; Ward DM; Kaplan J
    Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.